Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romain Marignier

Showing results (51-60 of 217) with videos related to

Pageof 22
Sort By:
Plos One|January 27, 2017
Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort StudyHadas Stiebel-Kalish, Itay Lotan, Judith Brody, et al.
European Journal of Neurology|July 15, 2026
Diagnostic Value of Spinal Cord Lesion Metabolism on [<sup>18</sup>F]FDG PET/CT for the Classification of MyelopathyAntoine Gavoille, Anthime Flaus, Matthieu Dietz, et al.
Journal of Neuroradiology = Journal De Neuroradiologie|April 15, 2019
Aquaporin 4 distribution in the brain and its relevance for the radiological appearance of neuromyelitis optica spectrum diseaseRoxana Ameli, Charles R G Guttmann, Juan Carlos Prieto, et al.
Journal of Neurology|June 26, 2018
Myelin oligodendrocyte glycoprotein-positive optic neuritis masquerading as pseudotumor cerebri at presentationItay Lotan, Judith Brody, Mark Andrew Hellmann, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 27, 2020
Dramatic efficacy of ofatumumab in refractory pediatric-onset AQP4-IgG neuromyelitis optica spectrum disorderElisabeth Maillart, Florence Renaldo, Caroline Papeix, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2015
Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implicationsÁlvaro Cobo-Calvo, María Sepúlveda, Raphael Bernard-Valnet, et al.
Neurology|February 6, 2025
Severe Relapse After Switching From Eculizumab to Satralizumab in Neuromyelitis Optica Spectrum DisorderElisabeth Maillart, Anne-Laure Dubessy, Natalia Shor, et al.
Neurology and Therapy|June 9, 2018
Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum DisordersChristine Lebrun, Mikael Cohen, Maria Alessandra Rosenthal-Allieri, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 16, 2021
Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody-Associated DiseasesAlexandre Avouac, Adil Maarouf, Jan-Patrick Stellmann, et al.
European Journal of Neurology|February 28, 2022
Is there a correlation between MOG-associated disorder and SARS-CoV-2 infection?Sara Mariotto, Sara Carta, Alessandro Dinoto, et al.
Pageof 22

Showing results (51-60 of 217) with videos related to

Sort By:
Pageof 22
Plos One|January 27, 2017
Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort StudyHadas Stiebel-Kalish, Itay Lotan, Judith Brody, et al.
European Journal of Neurology|July 15, 2026
Diagnostic Value of Spinal Cord Lesion Metabolism on [<sup>18</sup>F]FDG PET/CT for the Classification of MyelopathyAntoine Gavoille, Anthime Flaus, Matthieu Dietz, et al.
Journal of Neuroradiology = Journal De Neuroradiologie|April 15, 2019
Aquaporin 4 distribution in the brain and its relevance for the radiological appearance of neuromyelitis optica spectrum diseaseRoxana Ameli, Charles R G Guttmann, Juan Carlos Prieto, et al.
Journal of Neurology|June 26, 2018
Myelin oligodendrocyte glycoprotein-positive optic neuritis masquerading as pseudotumor cerebri at presentationItay Lotan, Judith Brody, Mark Andrew Hellmann, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 27, 2020
Dramatic efficacy of ofatumumab in refractory pediatric-onset AQP4-IgG neuromyelitis optica spectrum disorderElisabeth Maillart, Florence Renaldo, Caroline Papeix, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2015
Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implicationsÁlvaro Cobo-Calvo, María Sepúlveda, Raphael Bernard-Valnet, et al.
Neurology|February 6, 2025
Severe Relapse After Switching From Eculizumab to Satralizumab in Neuromyelitis Optica Spectrum DisorderElisabeth Maillart, Anne-Laure Dubessy, Natalia Shor, et al.
Neurology and Therapy|June 9, 2018
Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum DisordersChristine Lebrun, Mikael Cohen, Maria Alessandra Rosenthal-Allieri, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 16, 2021
Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody-Associated DiseasesAlexandre Avouac, Adil Maarouf, Jan-Patrick Stellmann, et al.
European Journal of Neurology|February 28, 2022
Is there a correlation between MOG-associated disorder and SARS-CoV-2 infection?Sara Mariotto, Sara Carta, Alessandro Dinoto, et al.
Pageof 22